First Long Island Investors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$40.5M Sell
44,075
-153
-0.3% -$155K 3.29% 8
2025
Q4
$47.5M Buy
44,228
+387
+0.9% +$370K 3.49% 8
2025
Q3
$33.5M Buy
43,841
+15,446
+54% +$11.5M 2.49% 14
2025
Q2
$22.1M Buy
28,395
+1,375
+5% +$1.07M 1.74% 22
2025
Q1
$22.3M Buy
27,020
+3,336
+14% +$2.78M 1.84% 22
2024
Q4
$18.3M Buy
23,684
+4,554
+24% +$3.77M 1.45% 28
2024
Q3
$16.9M Buy
19,130
+346
+2% +$311K 1.34% 30
2024
Q2
$17M Buy
18,784
+355
+2% +$284K 1.44% 30
2024
Q1
$14.3M Buy
18,429
+5,464
+42% +$3.89M 1.19% 37
2023
Q4
$7.56M Sell
12,965
-99
-0.8% -$57.8K 0.67% 47
2023
Q3
$7.02M Buy
13,064
+55
+0.4% +$28.3K 0.68% 48
2023
Q2
$6.1M Buy
+13,009
New +$5.46M 0.59% 47

Other funds holding LLY

First Long Island Investors's LLY Position: Q1 2026 in Review

First Long Island Investors reduced its Eli Lilly (LLY) stake by 0.35% in Q1 2026, selling an estimated $155K and leaving 44,075 shares worth $40.5M. The position accounts for 3.29% of the portfolio, ranked #8.

First Long Island Investors first reported a position in LLY in Q2 2023 and has held it in 12 quarters since. The position peaked at $47.5M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • First Long Island Investors held 44,075 shares of Eli Lilly worth $40.5M as of Q1 2026.
  • First Long Island Investors sold 153 Eli Lilly shares in Q1 2026, an estimated $155K.
  • Eli Lilly made up 3.29% of First Long Island Investors's portfolio in Q1 2026, its #8 holding.
  • First Long Island Investors first reported a position in Eli Lilly in Q2 2023 and has held it in 12 quarters since.
  • First Long Island Investors's Eli Lilly position peaked at $47.5M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on First Long Island Investors's 13F filing for Q1 2026, filed 15 May 2026.